Home Biosimilar Antibodies Angiogenesis EGFR Necitumumab (anti-EGFR) For research use only.
Not for use in humans.

Necitumumab (anti-EGFR)

Necitumumab (anti-EGFR) is an epidermal growth factor receptor (EGFR) antagonist that can be used in combination with gemcitabine and cisplatin for the first-line treatment of patients with metastatic squamous non-small cell lung cancer.

Necitumumab (anti-EGFR)

Click to purchase the isotype control of Necitumumab (anti-EGFR)

Purity & Quality Control

Batch: A204801 Purity: 98% Protein concentration: 4.6mg/ml Endotoxin Level: <1 EU/mg
98

Choose Selective EGFR Inhibitors

Biological Activity

Description Necitumumab (anti-EGFR) is an epidermal growth factor receptor (EGFR) antagonist that can be used in combination with gemcitabine and cisplatin for the first-line treatment of patients with metastatic squamous non-small cell lung cancer.

Product Details

CAS No. 906805-06-9
Molecular Weight 150 kDa
Isotype human IGg1, κ
Application Necitumumab (anti-EGFR)
Source CHO
Purification Protein G
Sterility 0.2 μM filtered
Formulation PBS Buffer, PH 7.4
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Necitumumab (anti-EGFR) | Necitumumab (anti-EGFR) supplier | purchase Necitumumab (anti-EGFR) | Necitumumab (anti-EGFR) cost | Necitumumab (anti-EGFR) manufacturer | order Necitumumab (anti-EGFR) | Necitumumab (anti-EGFR) distributor